| DMP | diffuse mesangial proliferation; dimercaprol; dimethylphthalate |
|---|---|
| DMH | diffuse mesangial hypercellularity |
| DMS | delayed match-to-sample; delayed microembolism syndrome; demarcation membrane system; department of ... |
| DILD | diffuse infiltrative lung disease; diffuse interstitial lung disease |
| MPGN | Mesangial(Membrano-) Proliferative Glomerulo-Nephritis |
| DMS | Diffuse mesangial sclerosis |
|---|---|
| LPT | Lymphocyte Proliferation Test |
| LP | Lymphocyte proliferation |
| MPP | Massive periretinal proliferation |
| PCNA | Proliferation Cell Nuclear Antigen |
| diffuse mesangial proliferation | <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome. Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine. Acronym: MPGN (05 Jan 1998) |
|---|
| mesangial | Referring to the mesangium. (05 Mar 2000) |
|---|---|
| mesangial cell | <pathology> Cells found within the glomerular lobules of mammalian kidney, where they serve as structural supports, may regulate blood flow, are phagocytic and may act as accessory cells, presenting antigen in immune responses. (18 Nov 1997) |
| mesangial nephritis | Glomerulonephritis with an increase in glomerular mesangial cells or matrix, or mesangial deposits. (05 Mar 2000) |
| mesangial proliferative glomerulonephritis | <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome. Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine. Acronym: MPGN (05 Jan 1998) |
| gingival proliferation | Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (12 Dec 1998) |
| regulatory cell proliferation kinase | <enzyme> Involved in mitosis regulation; has characteristics of serine/threonine and tyrosine kinases; isolated from saccharomyces cerevisiae; genbank l08909 Registry number: EC 2.7.1.- Synonym: rpk1 protein, rpk1 gene product (26 Jun 1999) |
| cell proliferation | <cell biology> Increase in cell number by division. (26 Mar 1998) |
| proliferation | <cell biology> The reproduction or multiplication of similar forms, especially of cells and morbid cysts. Origin: L. Proles = offspring, ferre = to bear (18 Nov 1997) |
| proliferation cyst | A mother cyst containing daughter cyst's; a cyst with tumourous formation at one portion of the sac. (05 Mar 2000) |
| proliferation therapy | Rehabilitation of an incompetent structure (ligament or tendon) by the induced proliferation of new cells; accomplished by injecting an irritating substance into the loose ligament or tendon, the resulting scar formation and contracture serving to tighten up the ligament or tendon as scar tissue proliferates. (05 Mar 2000) |
| cerebral sclerosis, diffuse | Diffuse progressive degeneration of the white matter of the brain, accompanied by mental deterioration, severe motor disturbances, and early death. (12 Dec 1998) |
| goiter, diffuse toxic | Graves' disease, the most common cause of hyperthroidism, too much thyroid hormone. (12 Dec 1998) |
| chronic diffuse sclerosing osteomyelitis | A proliferative reaction of bone to a low-grade infection of the jaws; most often seen in middle-aged or older black women as extensive, often bilateral radio-opacities of the mandible and maxilla. (05 Mar 2000) |
| hyperostosis, diffuse idiopathic skeletal | A disease of elderly men characterised by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions. (12 Dec 1998) |
| diffuse | Not definitely limited or localised, widely distributed. Origin: L. Dis = apart, fundere = to pour (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|